SCHEMBL5899462

SCHEMBL5899462

O=C(CNS(=O)(=O)c1ccccc1)c1ccc2ccccc2c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 3/20 0.71
PTPN1 P18031 1/20 0.51
ALDH1A1 P00352 2/20 0.50
GPR27 Q9NS67 1/20 0.50
CA12 O43570 4/20 0.49
CA1 P00915 4/20 0.49
CA2 P00918 4/20 0.49
CA9 Q16790 4/20 0.49
GABRB1 P18505 1/20 0.49
GABRB2 P47870 1/20 0.49
CTSS P25774 1/20 0.49
LMNA P02545 2/20 0.49
KDM4E B2RXH2 2/20 0.49
MEN1 O00255 1/20 0.49
MAPT P10636 1/20 0.49
KMT2A Q03164 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
POLB P06746 1/20 0.48
HPGD P15428 1/20 0.48
MMP1 P03956 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899507 0.90 KAT6A (0.66) KAT6AALDH1A1GPR27CA12CA1
SCHEMBL5899477 0.89 KAT6A (0.65) KAT6APTPN1ALDH1A1GPR27CA12
SCHEMBL5899421 0.89 KAT6A (0.65) KAT6APTPN1ALDH1A1GPR27CA12
SCHEMBL5899491 0.86 KAT6A (0.62) KAT6APTPN1ALDH1A1CA12CA1
SCHEMBL5899544 0.82 KAT6A (0.58) KAT6AALDH1A1LMNAKDM4EMEN1
SCHEMBL5899446 0.81 KAT6A (0.72) KAT6AALDH1A1CTSSMEN1KMT2A
SCHEMBL5899485 0.81 KAT6A (0.63) KAT6APTPN1CA12CA1CA2
SCHEMBL5899467 0.80 KAT6A (0.72) KAT6APTPN1CA1CA2LMNA
SCHEMBL23014100 0.78 HSD11B1 (0.66) KAT6AALDH1A1LMNAMEN1MAPT
SCHEMBL7672302 0.78 GPR27 (0.72) KAT6AALDH1A1GPR27LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 KAT6A 2440/4885PTPN1 2903/4885ALDH1A1 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.